Fibroma medical therapy

Jump to navigation Jump to search

Fibroma Microchapters


Patient Information


Historical Perspective




Epidemiology and Demographics

Risk Factors


Differentiating Fibroma from other Diseases

Natural History, Complications & Prognosis


Diagnostic Study of Choice

History and Symptoms

Physical Examination

X Ray




Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Case Studies

Case #1

Fibroma medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Fibroma medical therapy

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fibroma medical therapy

CDC on Fibroma medical therapy

Fibroma medical therapy in the news

Blogs on Fibroma medical therapy

Directions to Hospitals Treating Fibroma

Risk calculators and risk factors for Fibroma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maneesha Nandimandalam, M.B.B.S.[2]


The majority treatment of cases of fibromas is not medical therapy, but for some one's such as uterine fibroma does have medical therapy.Medical therapy depends on the type of fibroma.

Medical therapy

The majority treatment of cases of fibromas is not medical therapy, but for some one's such as uterine fibroma does have medical therapy.[1][2][3][4][5][6][7][8]

Uterine fibroma

Gonadotropin-Releasing Hormone Analogues

GnRH analogues With Add-Back Therapy


  1. 1.0 1.1 Sabry, Mohamed; Al-Hendy, Ayman (2012). "Medical Treatment of Uterine Leiomyoma". Reproductive Sciences. 19 (4): 339–353. doi:10.1177/1933719111432867. ISSN 1933-7191.
  2. 2.0 2.1 Donnez, Jacques; Dolmans, Marie-Madeleine (2016). "Uterine fibroid management: from the present to the future". Human Reproduction Update. 22 (6): 665–686. doi:10.1093/humupd/dmw023. ISSN 1355-4786.
  3. 3.0 3.1 Murji, Ally; Whitaker, Lucy; Chow, Tiffany L; Sobel, Mara L (2017). "Selective progesterone receptor modulators (SPRMs) for uterine fibroids". Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD010770.pub2. ISSN 1465-1858.
  4. 4.0 4.1 Arena, Saverio; Zupi, Errico (2011). "Heavy Menstrual Bleeding: Considering the Most Effective Treatment Option". Women's Health. 7 (2): 143–146. doi:10.2217/WHE.11.1. ISSN 1745-5065.
  5. 5.0 5.1 De Leo, Vincenzo; Morgante, Giuseppe; La Marca, Antonio; Musacchio, Maria Concetta; Sorace, Massimo; Cavicchioli, Chiara; Petraglia, Felice (2002). "A Benefit-Risk Assessment of Medical Treatment for Uterine Leiomyomas". Drug Safety. 25 (11): 759–779. doi:10.2165/00002018-200225110-00002. ISSN 0114-5916.
  6. 6.0 6.1 Sankaran, Srividhya; Manyonda, Isaac T. (2008). "Medical management of fibroids". Best Practice & Research Clinical Obstetrics & Gynaecology. 22 (4): 655–676. doi:10.1016/j.bpobgyn.2008.03.001. ISSN 1521-6934.
  7. 7.0 7.1 Palomba, S. (2002). "Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial". Human Reproduction. 17 (12): 3213–3219. doi:10.1093/humrep/17.12.3213. ISSN 1460-2350.
  8. 8.0 8.1 Golan, A. (1996). "GnRH analogues in the treatment of uterine fibroids". Human Reproduction. 11 (suppl 3): 33–41. doi:10.1093/humrep/11.suppl_3.33. ISSN 0268-1161.

Template:WH Template:WS